Critical Control Point Production Blood Components of Platelets

Abstract

Introduction: Blood transfusion is a health service effort in the form of medical actions giving directions to patients for the purpose of healing diseases and restoring health. The transfused concentrated platelet component must be able to provide the maximum therapeutic effect with the least possible reaction. This means that each bag of concentrated platelets produced must contain a sufficient number of platelets so that it is effective for patient safety. This study aims to describe how to obtain concentrated platelet products that have platelet levels in accordance with established standards by meeting critical control points for making concentrated platelet components.

Methods: This study uses a type of descriptive research with a quantitative approach which was carried out at the Indonesian Red Cross Blood Donor Unit of Tangerang City. The samples in this study were concentrated platelet products from Blood Transfusion Unit A as many as 16 samples. The sampling technique used is random sampling data processed using Microsoft Excel.

Result: Based on the results of the platelet product quality test inspection with a Refrigerated Centrifuge, the first round trial of the first round of 2000 XG for 3 minutes at temperature 22^oC with RC acceleration 9 and RC deceleration 4. Based on the results of the product quality test examination in February, it can be concluded that the TC blood component as many as 4 bags, the results of hematological examination on platelet levels show 0% results.

Conclusion: It can be concluded that the TC blood component as many as 4 bags, the results of hematology examination on platelet levels show 0% results. Critical Control Point is obtained, blood collection with one puncture, no repositioning, duration of collection less than 12 minutes, transportation of raw materials at 20-24^oC, processing duration less than 8 hours, product storage at 20-24^oC by agitation and closed.